WallStSmart

Monster Beverage Corp (MNST)vs22nd Century Group Inc (XXII)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Monster Beverage Corp generates 144928% more annual revenue ($8.79B vs $6.06M). MNST leads profitability with a 23.1% profit margin vs -65.8%. MNST earns a higher WallStSmart Score of 69/100 (B-).

MNST

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 9.0Value: 5.3Quality: 7.8
Piotroski: 4/9Altman Z: 6.29

XXII

Avoid

32

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 6.7Quality: 6.5
Piotroski: 4/9Altman Z: -20.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MNSTUndervalued (+65.6%)

Margin of Safety

+65.6%

Fair Value

$283.89

Current Price

$96.92

$186.97 discount

UndervaluedFair: $283.89Overvalued
XXIIUndervalued (+80.9%)

Margin of Safety

+80.9%

Fair Value

$29.44

Current Price

$4.22

$25.22 discount

UndervaluedFair: $29.44Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MNST6 strengths · Avg: 9.2/10
Operating MarginProfitability
31.0%10/10

Strong operational efficiency at 31.0%

Altman Z-ScoreHealth
6.2910/10

Safe zone — low bankruptcy risk

Market CapQuality
$94.26B9/10

Large-cap with strong market position

Return on EquityProfitability
23.3%9/10

Every $100 of equity generates 23 in profit

Profit MarginProfitability
23.1%9/10

Keeps 23 of every $100 in revenue as profit

Revenue GrowthGrowth
26.9%8/10

Revenue surging 26.9% year-over-year

XXII2 strengths · Avg: 10.0/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0610/10

Conservative balance sheet, low leverage

Areas to Watch

MNST3 concerns · Avg: 2.7/10
Price/BookValuation
10.9x4/10

Trading at 10.9x book value

PEG RatioValuation
2.782/10

Expensive relative to growth rate

P/E RatioValuation
46.6x2/10

Premium valuation, high expectations priced in

XXII4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.38M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-103.6%2/10

ROE of -103.6% — below average capital efficiency

Revenue GrowthGrowth
-43.3%2/10

Revenue declined 43.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : MNST

The strongest argument for MNST centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 23.1% and operating margin at 31.0%. Revenue growth of 26.9% demonstrates continued momentum.

Bull Case : XXII

The strongest argument for XXII centers on Price/Book, Debt/Equity.

Bear Case : MNST

The primary concerns for MNST are Price/Book, PEG Ratio, P/E Ratio. A P/E of 46.6x leaves little room for execution misses.

Bear Case : XXII

The primary concerns for XXII are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

MNST profiles as a growth stock while XXII is a turnaround play — different risk/reward profiles.

XXII carries more volatility with a beta of 0.60 — expect wider price swings.

MNST is growing revenue faster at 26.9% — sustainability is the question.

MNST generates stronger free cash flow (584M), providing more financial flexibility.

Bottom Line

MNST scores higher overall (69/100 vs 32/100), backed by strong 23.1% margins and 26.9% revenue growth. XXII offers better value entry with a 80.9% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Monster Beverage Corp

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Monster Beverage Corporation is an American beverage company that manufactures energy drinks including Monster Energy, Relentless and Burn.

Visit Website →

22nd Century Group Inc

CONSUMER DEFENSIVE · TOBACCO · USA

22nd Century Group Inc (Ticker: XXII) is a pioneering biopharmaceutical and agricultural firm focused on tobacco harm reduction via advanced genetic engineering. The company is committed to developing low-nicotine tobacco products to mitigate nicotine addiction, thereby promoting better public health outcomes. In addition to its core focus, 22nd Century is strategically expanding into the rapidly evolving hemp and cannabis markets, positioning itself favorably within the burgeoning legal cannabis industry. With a strong emphasis on scientific research and regulatory compliance, 22nd Century emerges as an attractive investment opportunity for institutional investors seeking to engage in transformative and socially responsible sectors.

Want to dig deeper into these stocks?